Charles D. Hyman’s Matinas BioPharma MTNB Stock Holding History

Charles D. Hyman’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$13K	Hold	1,596	–	–	﹤0.01%	242
2024 Q1	$22K	Hold	1,596	–	–	﹤0.01%	247
2023 Q4	$17K	Hold	1,596	–	–	﹤0.01%	242
2023 Q3	$10K	Hold	1,596	–	–	﹤0.01%	230
2023 Q2	$29K	Hold	1,596	–	–	﹤0.01%	235
2023 Q1	$38K	Hold	1,596	–	–	﹤0.01%	239
2022 Q4	$40K	Hold	1,596	–	–	﹤0.01%	239
2022 Q3	$51K	Hold	1,596	–	–	﹤0.01%	231
2022 Q2	$63K	Hold	1,596	–	–	﹤0.01%	237
2022 Q1	$64K	Hold	1,596	–	–	﹤0.01%	241
2021 Q4	$81K	Hold	1,596	–	–	0.01%	235
2021 Q3	$104K	Hold	1,596	–	–	0.01%	230
2021 Q2	$62K	Hold	1,596	–	–	﹤0.01%	232
2021 Q1	$84K	Hold	1,596	–	–	0.01%	231
2020 Q4	$109K	Hold	1,596	–	–	0.01%	230
2020 Q3	$61K	Hold	1,596	–	–	0.01%	222
2020 Q2	$62K	Hold	1,596	–	–	0.01%	213
2020 Q1	$48K	Hold	1,596	–	–	0.01%	183
2019 Q4	$181K	Hold	1,596	–	–	0.02%	203
2019 Q3	$50K	Hold	1,596	–	–	0.01%	185
2019 Q2	$68K	Hold	1,596	–	–	0.01%	186
2019 Q1	$87K	Hold	1,596	–	–	0.01%	185
2018 Q4	$47K	Hold	1,596	–	–	0.01%	169
2018 Q3	$73K	Hold	1,596	–	–	0.01%	178
2018 Q2	$35K	Hold	1,596	–	–	﹤0.01%	175
2018 Q1	$61K	Hold	1,596	–	–	0.01%	173
2017 Q4	$93K	Hold	1,596	–	–	0.01%	164
2017 Q3	$105K	Hold	1,596	–	–	0.01%	154
2017 Q2	$135K	Hold	1,596	–	–	0.02%	150
2017 Q1	$221K	Buy	+1,596	New	+$260K	0.03%	130

Other funds holding MTNB

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWMG

Alliance Wealth Management Group Flemington, New Jersey $457M AUM 12.13% 1-Year Est. Return

TCM

Towercrest Capital Management Newtown, Pennsylvania $642M AUM 11.71% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles D. Hyman's MTNB Position: Q2 2024 in Review

Charles D. Hyman held its Matinas BioPharma (MTNB) position steady in Q2 2024 at 1,596 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #242.

Charles D. Hyman first reported a position in MTNB in Q1 2017 and has held it in 30 quarters since. The position peaked at $221K in Q1 2017. 48 funds tracked by Wall St. Rank hold MTNB as of Q2 2024.

Charles D. Hyman held 1,596 shares of Matinas BioPharma worth $13K as of Q2 2024.
Charles D. Hyman left its Matinas BioPharma share count unchanged in Q2 2024.
Matinas BioPharma made up ﹤0.01% of Charles D. Hyman's portfolio in Q2 2024, its #242 holding.
Charles D. Hyman first reported a position in Matinas BioPharma in Q1 2017 and has held it in 30 quarters since.
Charles D. Hyman's Matinas BioPharma position peaked at $221K in Q1 2017.
48 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2024.

Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.